CSL LIMITED - Charts / Financials

1.66%

$183.64

Market Cap $87.09B

Healthcare Biotechnology

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

Compumedics Limited (ASX:CMP): FDA-Cleared AI Sleep & Brain Imaging Platforms. SaaS Recurring Revenues. U.S. Expansion Underway. CMP is Unlocking the Next MedTech Growth Story.

REFRESH

Last update - 16.17pm 10/02/2026 (20 minute delay)

Day
Open	$181.90		Day High	$184.34		Day Low	$181.35
Daily Volume	1040092

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
0	$171.35	1000		0	$171.39	4558

Directors & Senior Management

Ms. Alison Mary Watkins	Independent Non-Executive Director
Mr. Andy Schmeltz	Chief Commercial Officer
Dr. Brian A. McNamee	Independent Non-Executive Chairman
Dr. Brian F. Daniels	Independent Non-executive Director
Cameron Bruce Price	Director
Mr. Cameron James Price	Independent Non- Executive Director
Ms. Carolyn Judith Hewson	Independent Non-Executive Director
Chris Cooper	Head of Investor Relations
Mr. Constantine Saroukos	Director
Mr. Costa Saroukis	Director
Mr. Dave Ross	Senior VP & GM of Seqirus
Ms. Deirdre BeVard	Senior Vice President of Research & Development Strategic Operations
Ms. Elaine K. Sorg	Independent Non-Executive Director
Ms. Fiona Mead	Company Secretary & Head of Corporate Governance
Mr. Gordon Naylor	Director
Mr. Gregory Boss	Executive VP of Legal & Group General Counsel
Mr. Herve Gisserot	Executive VP of Business Development & Enterprise Alliance Management
Mr. Jeffrey Alan Ball	First Chief Sustainability Officer
Ms. Kate Sophie Priestman	Chief Corporate & External Affairs Officer
Mr. Ken Lim	Chief Financial Officer
Mr. Mark Hill	Chief Digital Information Officer & Executive VP
Dr. Mary Oates	Executive VP & COO
Dr. Paul F. McKenzie	MD, CEO & Executive Director
Ms. Roanne Parry	Chief Human Resources Officer
Dr. Robert Andrew Cuthbertson	Independent Non-Executive Director
Ms. Samantha Louise Lewis	Independent Non-executive Director
Dr. William Mezzanotte	Chief Medical Officer, Executive VP and Head of Research & Development

Data source: ADVFN

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $183.64		Change 3.000(1.66%)		Mkt cap ! $87.09B

Open	High	Low	Volume
$181.90	$184.34	$181.35	1.040M

Buyers (Bids)

Vol.	Price($)
1000	$171.35

Sellers (Offers)

Price($)	Vol.
$171.39	4558

Last trade - 16.17pm 10/02/2026 (20 minute delay)

CSL (ASX) Chart

CSL LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories